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Abstract
11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) catalyses intracellular regeneration of active glucocorticoids, notably in
liver and adipose tissue. 11b-HSD1 is increased selectively in adipose tissue in human obesity, a change implicated in the
pathogenesis ofmetabolic syndrome.With high fat (HF)-feeding, adipose tissue 11b-HSD1 is down-regulated inmice, plausibly
to counteract metabolic disease. Transcription of 11b-HSD1 is directly regulated by members of the CCAAT/enhancer binding
protein (C/EBP) family. Here we show that while total C/EBPb in adipose tissue is unaltered by HF diet, the ratio of the C/EBPb
isoforms liver-enriched inhibitor protein (LIP) and liver-enriched activator protein (LAP) (C/EBPb-LIP:LAP) is increased in
subcutaneous adipose. This may cause changes in 11b-HSD1 expression since genetically modified C/EBPb(+/L) mice, with
increased C/EBPb-LIP:LAP ratio, have decreased subcutaneous adipose 11b-HSD1 mRNA levels, whereas C/EBPbDuORF mice,
with decreased C/EBPb-LIP:LAP ratio, show increased subcutaneous adipose 11b-HSD1. C/EBPb-LIP:LAP ratio is regulated by
endoplasmic reticulum (ER) stress and mTOR signalling, both of which are altered in obesity. In 3T3-L1 adipocytes, 11b-HSD1
mRNA levels were down-regulated following induction of ER stress by tunicamycin but were up-regulated following inhibition
of mTOR by rapamycin. These data point to a central role for C/EBPb and its processing to LIP and LAP in transcriptional
regulation of 11b-HSD1 in adipose tissue. Down-regulation of 11b-HSD1 by increased C/EBPb-LIP:LAP in adipocytes may be
part of a nutrient-sensing mechanism counteracting nutritional stress generated by HF diet.
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Introduction
11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) is highly
expressed in liver and adipose tissue where it catalyses the
regeneration of active glucocorticoids (corticosterone, cortisol)
from inert 11keto- forms (11-dehydrocorticosterone, cortisone)
thus increasing intracellular glucocorticoid action [1]. 11b-HSD1
expression is elevated selectively in adipose tissue of obese humans
and in monogenic rodent genetic obesity, whereas levels in liver
are unaffected or even decreased [2,3,4]. Transgenic over-
expression of 11b-HSD1 in adipose tissue recapitulates the
metabolic syndrome in mice, with visceral obesity, dyslipidemia,
insulin resistance/diabetes and hypertension [2,5]. In contrast,
11b-HSD1-deficiency or inhibition causes insulin-sensitization
(including in humans), lowers fasting plasma glucose and lipid
levels, reduces visceral adipose tissue mass and attenuates
atherosclerosis [6,7,8]. Unexpectedly, high fat (HF) diet down-
regulated 11b-HSD1 selectively in adipose tissue in mice and rats
[9,10,11]. This down-regulation is greatest in obesity-resistant
strains [9] suggesting it may be a mechanism to minimise
metabolic disease with adiposity. Understanding the mechanisms
of adipose-specific control of 11b-HSD1 is crucial to dissecting the
pathogenesis of sensitivity/resistance to obesity.
Transcription of 11b-HSD1 is directly regulated by members of
theCCAAT/enhancer binding protein (C/EBP) family of transcrip-
tionfactors inall tissuesandcells studied[12,13,14,15,16].Thefamily
comprises 6members; C/EBPa, b, d, c, e and f (or CHOP) [17]. C/
EBPa,b, d andCHOPare essential for adipocyte differentiation and
function in vitro and in vivo [18,19,20,21]. C/EBPa and b each occur
as distinct isoforms arising from differential translation initiation or
proteolysis [22,23,24]. C/EBPa produces 42 kDa (p42) and 30 kDa
(p30) isoforms[22,24,25].C/EBPbexists as threemajor isoforms; the
38 kDa and 35 kDa liver-enriched activator protein isoforms (LAP*
and LAP, respectively), which stimulate transcription, and the
20 kDa liver-enriched inhibitor protein (LIP) [24]. LIP lacks the
transcription activation domain of C/EBPb and is typically
a dominant-negative regulator of C/EBP function [24]. The
LIP:LAP ratio is thus an important determinant of C/EBPb action
[26,27,28].
In vivo, C/EBPa is the major known inducer of 11b-HSD1
transcription in liver, where C/EBPb acts as a relative repressor
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37953
[12]. In contrast, in adipose tissue, C/EBPb is an activator [29].
Moreover, C/EBPb is required for glucocorticoid-induction of
11b-HSD1 in A549 cells [16] as well as regulation by IL-1b,
cAMP and ceramide in fibroblasts and 3T3-L1 preadipocytes
[13,14,30]. However, the crucial transcriptional regulation of 11b-
HSD1 in adipose tissue and mature adipocytes remains un-
explored. Here, we have tested the hypothesis that C/EBPs are
modulated by diet in mice and mediate the regulation of 11b-
HSD1 in adipose.
Materials and Methods
Animals
C57BL/6J mice (Harlan UK Ltd., Oxon, UK) were housed in
standard conditions on a 12 h light, 12 h dark cycle (lights on at
0700 h)at2161uC.Adultmalemice (n = 16/group)were fedcontrol
diet (11% calories as fat; diet D12328, Research Diets, Inc., New
Brunswick, NJ) or HF diet (58% calories as fat; diet D123331,
Research Diets) for 6 weeks. Adult male C/EBPb mutant mice,
heterozygous C/EBPb(+/L) and homozygous C/EBPbDuORF and
respective wild-type (WT) littermate control mice (n = 6–7/group)
were generated as previously described [31,32] and fed standard
chow diet. All animal experiments were conducted in strict accord
withaccepted standards of humaneanimal careunder theauspices of
the Animal (Scientific Procedures) Act UK 1986 and following prior
approvalbytheHomeOffice inUKorfollowingpriorapprovalbythe
Institutional Animal Care and Use Committee in Berlin, Germany.
3T3-L1 Adipocyte Differentiation and Transfection with
siRNA
3T3-L1 murine preadipocytes (ATCC, American Type Culture
Collection) were maintained and differentiated into mature adipo-
cytes as previously described [33]. Briefly, 2d after reaching
confluence,3T3-L1cellswere inducedtodifferentiatebytheaddition
of 0.5 mM dexamethasone, 500 mM 3-isobutyl-1-methylxanthine
and 5 mg/ml insulin for 2d. Thereafter, 3T3-L1 cell differentiation
continued in medium supplemented with 5 mg/ml insulin alone.
Experiments were performed 8–12d following induction of differen-
tiation, unless otherwise stated. 3T3-L1 adipocytes were transfected
with siRNA using DeliverX Plus (Panomics Inc., Fremont, CA)
according to the manufacturer’s protocol. Fully differentiated
adipocytesweregentlydetachedbyabriefwashwith trypsin followed
by collagenase type I (0.5 mg/ml; Invitrogen, Paisley, UK), and re-
seeded at 1.56105 cells perwell in a 12-well plate then transfected the
next day with siRNA (32 pmol) in serum-free medium for 3 h
followed by 21 h incubation in growth medium. All siRNAs were
purchased from Applied Biosystems (Warrington, UK) and were
scrambled (AM4611, negative control), C/EBPa (ID 101889), C/
EBPb (ID 288793) and CHOP (ID 288792). In the experiments
designed to induce ER stress, 3T3-L1 adipocytes were treated with
tunicamyin (4 mg/ml). Rapamycin (100 nMand 500 nM, 24 h) was
used to inhibit themammalian target of rapamycin (mTOR) in 3T3-
L1 adipocytes.
RNA Extraction and Analysis
Following dissection, subcutaneous adipose tissue (inguinal depot)
was frozen ondry ice and stored at270uC.Tissueswereweighted on
a balancemodel AA-160 (Denver Instrument Company, NY). RNA
was extracted using Qiagen RNeasy Lipid Tissue Mini kit (Qiagen,
WestSussex,UK).3T3-L1cellswereharvested inTrizol.RNA(2 mg)
was reverse transcribed using SuperScript III (Invitrogen) and
quantified by real-time PCR on a LightCycler 480 (Roche) as
described [16]. Primer-probe sets were purchased from Applied
Biosystems: 11b-HSD1 (Mm00476182_m1), C/EBPa
(Mm00514283_s1), C/EBPb (Mm00843434_s1), C/EBPd
(Mm00786711_s1) and CHOP (Mm00492097_m1). Routinely, at
least two internal standards were used from among 18S
(Hs99999901_s1), b-actin (Mm00607939_s1) and TATA binding
protein (TBP;Mm00446973_m1).
Western Blot Analysis
Subcutaneous adipose tissue (inguinal depot) was homogenized in
lysis buffer (0.125M Tris-HCL, pH 6.8, 2% sodium dodecyl
sulphate, and 10% glycerol) in the presence of a protease inhibitor
cocktail (P2714; Sigma-Aldrich, Dorset, UK) and heated at 100uC.
3T3-L1 adipocytes were harvested directly into lysis buffer and
processed similarly. Electrophoresis was carried out on 4–12%
NuPage Bis-Tris gels (Invitrogen). After transfer, blots were probed
withantibodies toC/EBPa, -b, -d (1:500dilutionof stock200 mg/ml;
Santa Cruz Biotechnology Inc., Santa Cruz, CA), CHOP (1:1000
dilution; ABcam, Cambridge, UK) and b-tubulin (1:10000 dilution;
Chemicon/Millipore,Watford, UK) and secondary antibodies anti-
rabbit IgG-HRP (1:2000 dilution from stock 400 mg/ml Santa Cruz
Biotechnology Inc.), anti-mouse IgG-HRP (1:4000 dilution; Cell
signaling, Danvers, MA), anti-rabbit IgG Alexa Fluor 700 (Invitro-
gen) and anti-mouse IgG (Rockland Immunochemicals Inc.
Gilbertsville, PA). The resulting bands were analyzed by ImageJ
(NIH, USA) or the Odyssey Infrared Imaging System (LI-COR
Biosciences Ltd, Cambridge, UK), as appropriate.
Chromatin Immunoprecipitation (Chip) Assays
ChIP assays were carried out using an Upstate EZ ChIP kit
(Millipore, Billerica, MA) according to the manufacturer’s pro-
tocol. Briefly, differentiating 3T3-L1 cells (8 h after induction of
differentiation) or fully mature adipocytes (differentiated for 9d) in
15 cm tissue culture dishes were incubated with dimethyl
adipimidate.2 HCL (10 mM in PBS; Thermo Fisher Scientific
Cramlington, UK) for 30 min in the dark followed by 1% (v/v)
formaldehyde. Cells were lysed in sodium dodecyl sulphate buffer
(provided in the kit). Chromatin was sheared by sonication using
a Soniprep 150 (MSE; Beckenham, Kent, UK) with eight 10 s
pulses, at maximum amplitude, keeping cells on ice between
pulses. Immunoprecipitations were carried out with 5 mg C/EBP
or control rabbit IgG antibody (Santa Cruz). After reversal of
cross-links, purified DNA was amplified by standard PCR (35
cycles of 94uC 30 s, 56uC 1 min, 72uC 1 min) or real-time PCR
(95uC 5 s, 65uC 1 min) as above, using primers spanning the
following C/EBP-binding sites in the 11b-HSD1 promoter [12]:
footprint FP1 and FP2 (59-CTAGTGCTGCCTGAGAC-
TACTCC-39 and 59-TTTTCATAACTGCCATCAAACAG-39),
FP3 and FP4 (59- CAGTAGGAGATGCTCAGGAACC-39 and
59-AGAGCAACGATTGGCTTTGG-39), FP9 (59-
ACTTGCCTGAGAGTCTTGAACTG-39 and 59-AGCAAAA-
TAAGCTCAAGGGAAAA-39) and a C/EBPb binding site in the
C/EBPa promoter (59-GGTGACTTAGAGGCTTAAAGGAG-
39 and 59-GTGACTTTCCAAGGCGGTGAGT-39). Primers
spanning an 11b-HSD1 intronic sequence not predicted to bind
C/EBP were used as a control (59-TCAAACATC-
CAGGTTCTTTCATT-39 and 59-CATACCACATAAACCA-
CACATGG-39). Data are expressed relative to levels of input
DNA in immunoprecipitations.
Statistical Analysis
All data were analyzed by Student’s t test or ANOVA followed
by post hoc Tukey, Fisher LSD or Dunnet tests using SigmaStat
2.03 statistical software. Significance was set at p#0.05.
LIP:LAP Ratio Regulates 11b-HSD1
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Results
Effect of HF Diet on 11b-HSD1 and C/EBP Expression in
Mouse Adipose Tissue
Mice fed HF diet for 6 weeks were heavier (HF, 30.860.52 vs
control diet, 26.360.34 g; p,0.01) with increased subcutaneous
adipose tissue weight (HF, 0.02260.001 vs control, 0.01260.001
(w/w) corrected for body weight; p,0.01), while liver weight
was unchanged (HF, 0.04960.001 vs control, 0.04660.003 (w/
w) corrected for body weight). 11b-HSD1 mRNA was down-
regulated in adipose tissue by HF diet both in subcutaneous
(Fig. 1A) and visceral (mesenteric) depots (data not shown), but
Figure 1. Expressionof11b-HSD1,C/EBPa,b,dandCHOPinadiposetissueofHFdiet-fedmicecomparedtocontroldiet-fedmice. (A)Real-
timePCRmeasurements of levels ofmRNAencoding11b-HSD1, C/EBPa,b,d, andCHOP in adipose tissueofHF-fed (blackbars) and control diet-fed (white
bars)mice. LevelsofmRNA,normalized toTBP, are expressed relative to levels in control diet-fedmice, arbitrarily set to 100%. (B-E) Representativewestern
blots (50 mgprotein/lane) andquantificationofblots probedwith; (B) C/EBPa antibody showing levels of the42 kDa (p42) and30 kDa (p30) isoformsofC/
EBPaaswellastotalC/EBPa (p42+p30) levels (the intermediateimmunoreactiveprotein indicatedby* is likelytobeaproteolyticproductofp42); (C)C/EBPb
antibody showing levels of LAP (38 kDa LAP* +35 kDa LAP) and the 20 kDa LIP isoforms of C/EBPb as well as total C/EBPb (LAP+LIP) levels (inset shows
LIP:LAP ratio); (D) C/EBPd antibody and (E) CHOP antibody showing levels of respective proteins in adipose tissue of mice fed HF diet (HF, black bars) or
control diet (C, white bars). Blotswere stripped and reprobedwith b-tubulin antibody, as loading control. In C/EBPb andCHOPwesterns, all sampleswere
analysed in the same gel but not all in adjacent lanes. C/EBP levels were quantified relative to b-tubulin levels using ImageJ analysis and are expressed in
arbitrary units (AU). All values are mean6SEM; n= 16/group (A) or 4/group (B-E). *, p#0.05; **, p,0.001.
doi:10.1371/journal.pone.0037953.g001
LIP:LAP Ratio Regulates 11b-HSD1
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was unchanged in liver (data not shown), consistent with
previous data showing down-regulation of 11b-HSD1 mRNA
and enzyme activity in adipose tissue of mice fed HF diet
[9,11]. To test whether altered C/EBP expression may underlie
the dietary regulation of 11b-HSD1, we examined C/EBPa, b,
d and CHOP expression in adipose tissue. HF diet did not
change C/EBPa, b or d mRNA levels, while CHOP mRNA
levels were increased in subcutaneous adipose tissue (Fig. 1A)
and mesenteric [11] adipose tissue (data not shown). Because
11b-HSD1 and C/EBP mRNA levels showed the same pattern
of changes in both adipose depots of HF-fed (vs control)
animals, subcutaneous adipose, which is more abundant, was
used for subsequent analyses. Consistent with mRNA levels,
western blot analysis showed an increase in CHOP protein
Figure 2. Transfection of fully differentiated 3T3-L1 adipocytes with C/EBPa or C/EBPb siRNA decreases 11b-HSD1 mRNA levels,
whilst CHOP siRNA has no effect. (A) Real-time PCR measurement of levels of mRNA encoding C/EBPa (left panel), C/EBPb (centre panel) and
CHOP (right panel), 24 h after transfection of fully differentiated 3T3-L1 adipocytes with scrambled RNA (Scr; as control) or siRNAs (32 pmol) targeting
C/EBPa, b or CHOP. Data are normalized to TBP and expressed relative to levels in cells transfected with scrambled RNA (arbitrarily set to 100%).
Values are mean6SEM of 3 different experiments (independent adipocyte differentiations) with each siRNA treatment tested in triplicate.
*, Significantly different from scrambled RNA, p#0.05. (B) Representative western blots showing levels of the 42 kDa (p42) and 30 kDa (p30) isoforms
of C/EBPa (left panel; 20 mg protein/lane), 38 kDa LAP*, 35 kDa LAP and 20 kDa LIP isoforms of C/EBPb (centre panel; 40 mg protein/lane) and CHOP
(right panel; 20 mg protein/lane), 24 h after transfection of 3T3-L1 adipocytes with scrambled RNA or respective siRNAs targeting C/EBPa, b or CHOP.
Blots were stripped and reprobed with b-tubulin antibody, as loading control. In C/EBPb and CHOP westerns all samples were analysed in the same
gel but not all in adjacent lanes. (C) Real-time PCR measurement of mRNA encoding 11b-HSD1, 24 h after transfection of 3T3-L1 mature adipocytes
with scrambled RNA or siRNA (32 pmol) targeting C/EBPa, b or CHOP. Data are normalized to TBP and expressed relative to levels in cells transfected
with scrambled RNA (arbitrarily set to 100%). Values are mean6SEM of 3 to 4 different experiments (independent adipocyte differentiations) with
each siRNA treatment tested in triplicate. *, Significantly different from scrambled RNA, p#0.05.
doi:10.1371/journal.pone.0037953.g002
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levels but no alteration in total C/EBPa (p42+ p30 isoforms),
total C/EBPb (LAP* + LAP + LIP) or C/EBPd (Fig. 1B–E)
protein levels with HF diet. However, HF diet reduced adipose
tissue levels of the C/EBPb-LAP*+LAP isoforms, concomitantly
increasing levels of C/EBPb-LIP (Fig. 1C), resulting in
a significant increase in the C/EBPb-LIP:LAP ratio (Fig. 1C,
inset).
C/EBPa and C/EBPb, but not CHOP, Regulate Expression
of 11b-HSD1 in 3T3-L1 Adipocytes
Increased CHOP levels or increased C/EBPb-LIP:LAP ratio
could plausibly reduce adipose 11b-HSD1 expression. The effect
of CHOP on 11b-HSD1 expression has not been reported.
Moreover, although C/EBPb regulates 11b-HSD1 expression
during preadipocyte differentiation [13,29], any role in mature
adipocytes has not been tested. To investigate the requirement
for C/EBPa, C/EBPb and CHOP in 11b-HSD1 expression in
adipocytes, 3T3-L1 preadipocytes were fully differentiated into
mature adipocytes, which show high endogenous expression of
11b-HSD1 [33], and then transfected with siRNAs to decrease
levels of C/EBPa, C/EBPb or CHOP. Measurement of mRNA
and protein levels confirmed the reduction in expression of
appropriate C/EBPs with siRNA, notably reducing all isoforms
of C/EBPa and C/EBPb (Fig. 2A, B) but increasing C/EBPb-
Figure 3. Binding of C/EBPa and C/EBPb to the promoter of 11b-HSD1 throughout 3T3-L1 adipocyte differentiation. (A) Relevant C/
EBP binding sites in the mouse 11b-HSD1 promoter; FP1 to 4 and 9. The start of transcription (+1) [12] is indicated with a bent arrow. The indicated C/
EBP binding sites are highly conserved between the rat and mouse 11b-HSD1 promoters [12,13] and are named according to the sites in the rat
promoter [12]. PCR products amplified in the ChIP experiment are indicated (a to c). (B) and (C) ChIP assays carried out to examine C/EBP binding to
the 11b-HSD1 promoter in (B) differentiating 3T3-L1 adipocytes (8 h after induction of differentiation) and (C) fully differentiated adipocytes (9d after
induction of differentiation). Left panels show representative gels of ChIP assays following immunoprecipitation with C/EBPa or C/EBPb antibody.
Control reactions contained rabbit IgG. PCR reactions (35 cycles) were carried out on input DNA (input) or on immunoprecipitated DNA with primers
spanning FP1/2 of the 11b-HSD1 promoter (lanes marked a), FP3/4 (lanes marked b), FP9 (lanes marked c), an intronic sequence from the 11b-HSD1
gene not predicted to bind C/EBP (lanes marked d) and a C/EBPb binding site in the C/EBPa promoter [44] (lanes marked e). In (B), all PCR products
were visualized in the same gel but not in adjacent lanes, whereas in (C), all PCR reactions were performed at the same time but were visualized in
different gels. Right panels show real-time PCR quantification of C/EBPa and C/EBPb binding to the FP1/2 and FP3/4 regions of the 11b-HSD1
promoter. Reactions were performed with the same primers used for standard PCR as detailed in Methods. ND, not detected. Values are mean6SEM
from 2 to 3 independent experiments and each sample was analysed in triplicate.
doi:10.1371/journal.pone.0037953.g003
LIP:LAP Ratio Regulates 11b-HSD1
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LIP:LAP ratio (scrambled RNA, 0.560.03 vs C/EBPb siRNA
0.760.02). The results also showed that reduced expression of
one of the C/EBPs in mature 3T3-L1 adipocytes did not affect
mRNA levels of the other C/EBPs tested (Fig. 2A). Both C/
EBPa and C/EBPb siRNA reduced 11b-HSD1 mRNA levels in
3T3-L1 adipocytes (Fig. 2C), demonstrating that both these
members of the C/EBP family play a key role in maintaining
adipocyte expression of 11b-HSD1. In contrast, although levels
of CHOP were reduced in 3T3-L1 adipocytes by siRNA
(Fig. 2A, B), this did not alter 11b-HSD1 mRNA levels (Fig. 2C).
C/EBPb Locates to the Promoter of 11b-HSD1
throughout Adipocyte Differentiation Whilst C/EBPa
Binds Only in Differentiated Adipocytes
Previous reports showed C/EBPb binding to the 11b-HSD1
promoter in undifferentiated 3T3-L1 preadipocytes [13,14], but
this has not been described in adipocytes. To determine if C/EBPs
interact with the 11b-HSD1 promoter in immature and fully
mature adipocytes, binding of C/EBPa and b was assayed by
chromatin immunoprecipitation (ChIP). The proximal promoter
of the rat 11b-HSD1 gene contains 4 C/EBP binding sites
between -196 and +44; footprints (FP) 1 to 4, which are conserved
in the mouse promoter [12,13] (Fig. 3A). C/EBPb was bound to
the proximal 11b-HSD1 promoter early during adipocyte
differentiation (when 11b-HSD1 expression is low) (Fig. 3B) as
well as in fully differentiated 3T3-L1 adipocytes (Fig. 3C). In
contrast, C/EBPa was only bound to the 11b-HSD1 proximal
promoter in fully differentiated 3T3-L1 adipocytes, which highly
express 11b-HSD1 [33]. Neither C/EBPa nor C/EBPb were
detected at FP9 in the promoter of 11b-HSD1 (also conserved
between rat and mouse) (Fig. 3B, C). Thus C/EBPb interacts
directly with the 11b-HSD1 promoter in mature adipocytes.
Increased C/EBPb-LIP:LAP Ratio in vivo Decreases 11b-
HSD1 mRNA Levels in Adipose Tissue, an Effect Reversed
in Mice with Decreased C/EBPb-LIP:LAP Ratio
To testwhether alteredC/EBPb-LIP:LAPratio can similarly alter
adipose 11b-HSD1 expression in vivo, we measured 11b-HSD1
mRNA levels in subcutaneous adipose tissue ofC/EBPb(+/L) andC/
EBPbDuORF mice which have increased and decreased C/EBPb-
LIP:LAP ratio, respectively. In C/EBPb(+/L) mice, a ‘‘knock-in’’ of
C/EBPb-LIP (L allele) replaces the normal C/EBPb gene [31],
increasing C/EBPb-LIP:LAP ratio (Fig. 4A). In C/EBPbDuORF
mice, deletion of the upstream open reading frame (DuORF allele)
prevents translation ofC/EBPb-LIP [32], thus decreasingC/EBPb-
LIP:LAP ratio (Fig. 4A). 11b-HSD1mRNA levels were significantly
lower in adipose tissue of C/EBPb(+/L) mice (increased C/EBPb-
LIP:LAP ratio) than in wild-type controls (Fig. 4B). The reverse was
observed inC/EBPbDuORFmice (Fig.4B), demonstrating that, in vivo,
theC/EBPb-LIP:LAP ratio controls the transcriptionof 11b-HSD1.
11b-HSD1 mRNA Levels are Down-regulated by ER Stress
in 3T3-L1 Adipocytes
Elevated C/EBPb-LIP:LAP ratio and CHOP levels, observed
in adipose tissue of HF-fed mice, may be a result of ER stress
[34,35]. Treatment of differentiated 3T3-L1 adipocytes with
tunicamycin, an inducer of ER stress [35], significantly reduced
11b-HSD1 mRNA levels at 6 h, with a more pronounced effect at
16 h (Fig. 5A). Similar results were obtained with an alternative
ER stress-inducer, thapsigargin (data not shown). Down-regulation
of 11b-HSD1 mRNA was accompanied by up-regulation of genes
increased by ER stress; CHOP and the 78 kDa glucose-regulated
protein (GRP78) (Fig. 5C, E), though calreticulin mRNA levels
were unaffected at this stage (Fig. 5D). C/EBPb mRNA levels
were not altered (Fig. 5B) whilst, as expected, C/EBPb-LIP:LAP
ratio was increased, and both C/EBPb-LAP and -LIP were up-
regulated (Fig. 5F). These results show that induction of ER stress,
which increases the C/EBPb-LIP:LAP ratio, also down-regulates
11b-HSD1 in 3T3-L1 adipocytes.
mTOR Regulates the Expression of 11b-HSD1 in 3T3-L1
Adipocytes
The mTOR pathway, which is responsive to nutrient availabil-
ity and growth factors, controls many aspects of cellular
Figure 4. Altered C/EBPb-LIP:LAP ratio in vivo affects 11b-HSD1
expression in adipose tissue. (A) Representative western blot
(40 mg protein/lane) showing levels of C/EBPb-LAP (38 kDa LAP*
+35 kDa LAP) and -LIP (20 kDa) isoforms in the adipose tissue of C/
EBPb mutants C/EBPb(+/L) (+/L), C/EBPbDuORF (DuORF) and control (Con)
mice. Blots were stripped and reprobed with b-tubulin antibody, as
loading control. All samples were analysed in the same gel but not all in
adjacent lanes. (B) Real-time PCR measurement levels of mRNA
encoding 11b-HSD1 in adipose tissue of wild type control mice (Con,
white bar), C/EBPb(+/L) (+/L, black bar) and C/EBPbDuORF (DuORF, grey
bar). C/EBPb(+/L) mice are heterozygous for an allele of C/EBPb in which
the normal gene has been replaced by C/EBPb-LIP (a ‘‘knock-in’’) [31]
and C/EBPbDuORF is homozygous for the deletion of upstream ORF
codon [32]. Adipose 11b-HSD1 mRNA levels, normalized to TBP, are
expressed relative to levels in control mice (arbitrarily set to 100%) and
are mean6SEM; n= 6–9/group. *, p#0.05; **, p,0.001.
doi:10.1371/journal.pone.0037953.g004
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Figure 5. Tunicamycin-induced ER stress reduces 11b-HSD1 expression in 3T3-L1 adipocytes. (A–E) Real-time PCR measurement of levels
of mRNA encoding (A) 11b-HSD1, (B) C/EBPb, (C) CHOP, (D) calreticulin and (E) GRP78 in untreated differentiated 3T3-L1 adipocytes (white bars) or
treated with tunicamycin (4 mg/ml, black bars) for 6 or 16 h. Data are normalized to TBP and expressed relative to levels of control cells (arbitrarily set
to 100%). (F) Representative western blot (40 mg protein/lane) and quantification showing levels of C/EBPb-LAP (38 kDa LAP* +35 kDa LAP) and -LIP
(20 kDa) isoforms. Inset shows C/EBPb-LIP:LAP ratio in untreated 3T3-L1 adipocytes (C, white bar) or treated with tunicamycin for 0.5 h (0.5 h, grey
bar) or 2 h (2 h, black bar). Blots were stripped and reprobed with b-tubulin antibody, as loading control. All samples were analysed in the same gel
but not in adjacent lanes. C/EBPb levels were quantified relative to b-tubulin and are expressed in arbitrary units (AU). Values are mean6SEM of 2–3
independent adipocyte differentiations with each treatment tested in duplicate or triplicate. *, Significantly different from control. *, p#0.05;
**, p,0.001; ***, p,0.0001.
doi:10.1371/journal.pone.0037953.g005
LIP:LAP Ratio Regulates 11b-HSD1
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37953
metabolism and regulates the production of C/EBPb-LIP and -
LAP isoforms [24]. To test the importance of this pathway for the
transcriptional regulation of 11b-HSD1, rapamycin was used to
inhibit mTOR in differentiated 3T3-L1 adipocytes. Rapamycin
did not alter C/EBPb mRNA levels (Fig. 6A) or C/EBPb-LAP,
but decreased C/EBPb-LIP, resulting in a lower C/EBPb-
LIP:LAP ratio (Fig. 6C). This was associated with increased 11b-
HSD1 mRNA levels (Fig. 6B). These results show that the mTOR
signalling pathway regulates 11b-HSD1 transcription in adipo-
cytes, plausibly via modulation of the C/EBPb-LIP:LAP ratio.
Discussion
This study emphasises the key role played by members of the
C/EBP family in the regulation of 11b-HSD1 transcription in
adipocytes. However, the main finding here is that the striking
down-regulation of 11b-HSD1 in adipose tissue of mice in
response to HF feeding is likely due to changes in post-
transcriptional processing of C/EBPb generating an increased
C/EBPb-LIP:LAP ratio. Indeed, knock-down of C/EBPb in fully
differentiated mature 3T3-L1 adipocytes showed that C/EBPb is
required for normal 11b-HSD1 expression in differentiated
adipocytes, consistent with a previous report of reduced 11b-
HSD1 expression in adipose tissue of C/EBPb-deficient mice [29].
In differentiating 3T3-L1 adipocytes, C/EBPb binds to the C/
EBPa promoter and induces its expression [20]. Importantly, in
contrast, knock-down of C/EBPb in fully differentiated adipocytes
did not affect levels of C/EBPa, suggesting a direct role for C/
EBPb in adipocyte 11b-HSD1 expression, independent of its effect
on C/EBPa expression. Indeed, C/EBPa mRNA and protein
levels were unchanged in adipose tissue of HF diet-fed mice.
However, it cannot be excluded that C/EBPb may also exert its
effect by regulating C/EBPa transactivation potential. Neverthe-
less, supporting a direct role, C/EBPb was bound to the 11b-
HSD1 promoter in mature adipocytes as well as in 3T3-L1
preadipocytes during the differentiation process. C/EBPa, in
contrast, was only bound to the 11b-HSD1 promoter in
Figure 6. Inhibition of mTOR in 3T3-L1 adipocytes reduces C/EBPb-LIP:LAP ratio and increases 11b-HSD1 expression. Real-time PCR
measurement of levels of mRNA encoding (A) C/EBPb and (B) 11b-HSD1 in 3T3-L1 adipocytes (white bars) or following treatment with 100 nM (grey
bars) or 500 nM (black bars) rapamycin for 24 h. Data are normalized to TBP and expressed relative to levels of control cells (arbitrarily set to 100%).
(C) Representative western blot (40 mg protein/lane) and quantification showing levels of C/EBPb-LAP (38 kDa LAP* +35 kDa LAP) and -LIP (20 kDa)
isoforms and inset showing C/EBPb-LIP:LAP ratio in untreated 3T3-L1 adipocytes (C, white bars) or following treatment with 100 nM (100, grey bars)
or 500 nM (500, black bars) rapamycin for 24 h. Blots were stripped and reprobed with b-tubulin antibody, as loading control. All samples were
analysed in the same gel but not in adjacent lanes. C/EBPb levels were quantified relative to b-tubulin and are expressed in arbitrary units (AU). Values
are mean6SEM of up to 3 independent adipocyte differentiations, each treatment tested in triplicate. *, Significantly different from control. *, p#0.05;
**, p,0.001.
doi:10.1371/journal.pone.0037953.g006
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differentiated adipocytes, as expected from its later appearance
during differentiation [20]. Thus, both C/EBPa and C/EBPb
play a direct and positive role in regulation of 11b-HSD1
transcription in differentiated adipocytes, but C/EBPb alone is
crucial in differentiating cells. This is likely to impact on the 11b-
HSD1 mRNA levels in these cells, where C/EBPa is absent or in
low levels. In adipose tissue, C/EBPb and CHOP were the only
C/EBPs changed by HF diet. Although CHOP generally represses
transcription [36], it can also be a co-activator [37]. However,
siRNA-mediated knock-down of CHOP showed that it plays no
role in 11b-HSD1 expression in fully differentiated 3T3-L1
adipocytes, although we cannot rule out that increased CHOP
levels may contribute to the down-regulation of 11b-HSD1 in
adipose tissue with HF diet.
An altered C/EBPb-LIP:LAP ratio, like the HF-induced
increase in CHOP, might be a response to ER stress as
a consequence of a high demand for ER activity with nutrient
excess [34]. The C/EBPb-LIP:LAP ratio is controlled by the
double stranded RNA-dependent protein kinase (PKR, a target of
ER stress [38]) and mTOR signalling pathways through the
eukaryotic translation factors eIF-2a and eIF-4E, respectively [24].
Indeed, diet-induced obesity in mice results in the activation of ER
stress pathways in metabolically relevant tissues, such as adipose
and liver, with increased phosphorylation of the PKR-like kinase
and its substrate eIF-2a, which are key indicators of ER stress [34].
mTOR may contribute to the ER stress response as well [39]. Our
results show that both induction of ER stress and inhibition of
mTOR signalling alter C/EBPb-LIP:LAP ratio and modulate
11b-HSD1 mRNA levels in 3T3-L1 adipocytes. ER stress and
mTOR signalling pathways are sensitive to cellular nutrients and
energy homeostasis, suggesting that the increased C/EBPb-
LIP:LAP ratio in obese adipose tissue may result from activation
of these nutrient/stress sensing mechanisms leading to the down-
regulation of 11b-HSD1.
Alterations in C/EBPb-LIP:LAP ratio are likely to impact upon
other metabolically-important genes, many of which, like 11b-
HSD1, are regulated by C/EBPb [40,41]. Indeed, the gene
encoding phosphoenolpyruvate carboxykinase, a C/EBPb-regu-
lated enzyme with key roles in hepatic gluconeogenesis and
adipose glycerogenesis, is down-regulated by an increased
LIP:LAP ratio [26]. C/EBPb-null mice have decreased gluconeo-
genesis and lipolysis during fasting or diabetes [40,41], resist diet-
induced obesity [42] and exhibit attenuated ER stress and
inflammatory responses [43]. Importantly, mice deficient in C/
EBPb lack both LIP and LAP isoforms and so are not informative
regarding the relevance of the C/EBPb-LIP:LAP ratio. In
contrast, gene targeted C/EBPb(+/L) and C/EBPbDuORF mice,
have altered levels of the C/EBPb isoforms. C/EBPbDuORF mice
show activation of acute-phase response genes after partial
hepatectomy, suggesting that C/EBPb-LIP may be a natural
restraint of inflammation [32]. However, the impact of the C/
EBPb-LIP:LAP ratio on 11b-HSD1 expression has not been
previously reported. Here, we demonstrate that manipulation of
the C/EBPb-LIP:LAP ratio regulates the expression of 11b-
HSD1, in agreement with the modulation of 11b-HSD1 mRNA
levels observed in mouse adipose tissue by diet.
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